WithdrawnPhase 2NCT02119728
Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity
Studying Squamous cell carcinoma of the lip
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Roswell Park Cancer Institute
- Principal Investigator
- Hassan ArshadRoswell Park Cancer Institute
- Intervention
- HPPH(drug)
- Eligibility
- 18 years · All sexes
Study locations (1)
- Roswell Park Cancer Institute, Buffalo, New York, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02119728 on ClinicalTrials.gov